Osivax today announced that it has received a grant of over $1.5 million from the U.S. National Institute of Allergy and Infectious Diseases (NIAID). The grant will support preclinical studies evaluating the breadth of protection and... READ →
Precision Vaccinations/ December 5th, 2023
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Dec 5 • 5:05 am CST
Dec 4 • 4:56 pm CST
With the winter months ahead, most hikers are not focused on catching Lyme disease. However, once the snow melts, millions of people will once again not have access to a vaccine. There are currently no approved... READ →
Dec 4 • 5:09 am CST
Valneva SE today announced positive antibody persistence data twenty-four months after vaccination with a single dose of its chikungunya vaccine IXCHIQ® . As reported on December 4, 2023, 97% of the 316 healthy adults still enrolled... READ →
Dec 2 • 10:28 am CST
As the multi-year Zika vaccine development process continues in late 2023, the mosquito-spreading disease is impacting more people in the Region of the Americas. As of December 2, 2023 , the Pan American Health Organization's data... READ →
Dec 2 • 8:27 am CST
The New England Journal of Medicine recently published results from late-stage clinical trials that concluded among persons with early Alzheimer's disease (AD), the use of Gantenerumab led to a lower amyloid plaque burden than placebo at... READ →
For more articles, try our search.